Cronos Group Inc. (NASDAQ:CRON – Free Report) – Equities researchers at Roth Capital raised their FY2024 earnings estimates for Cronos Group in a report issued on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will earn ($0.06) per share for the year, up from their previous estimate of ($0.08). The consensus estimate for Cronos Group’s current full-year earnings is ($0.05) per share.
Cronos Group Trading Down 2.9 %
NASDAQ:CRON opened at $2.01 on Friday. The stock’s 50-day moving average is $2.17 and its 200-day moving average is $2.35. The stock has a market cap of $768.42 million, a P/E ratio of -15.46 and a beta of 0.98. Cronos Group has a 1-year low of $1.85 and a 1-year high of $3.14.
Institutional Investors Weigh In On Cronos Group
About Cronos Group
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Stories
- Five stocks we like better than Cronos Group
- 3 Small Caps With Big Return Potential
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Business Services Stocks Investing
- Top-Performing Non-Leveraged ETFs This Year
- How to Use Stock Screeners to Find Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.